Navigation Links
Patient Safety Technologies Reports Third Quarter 2011 Results
Date:11/15/2011

sh equivalents$

4,957,495$

1,896,034Restricted cash-223,630Accounts receivable1,043,093772,381Inventories, net1,677,1001,110,832Prepaid expenses54,430104,628Total current assets7,732,1184,107,505Property and equipment, net1,111,697979,833Goodwill1,832,0271,832,027Patents, net2,545,3772,789,083Other assets34,23339,038Total assets$

13,255,452$

9,747,486Liabilities and Stockholders' EquityCurrent liabilitiesAccounts payable$

1,704,705$

2,605,669Accrued liabilities435,978991,682Deferred revenue330,3091,477,720Warrant derivative liability463,838942,472Total current liabilities2,934,8306,017,543Commitments and contingenciesStockholders' equity Total stockholders' equity10,320,6223,729,943Total liabilities and stockholders' equity$

13,255,452$

9,747,486PATIENT SAFETY TECHNOLOGIES, INC.Condensed Consolidated Statements of Operations(Unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Revenues$

2,186,220$

4,122,560$

6,725,646$

10,252,897Cost of revenue1,190,8791,950,5733,528,1104,829,821Gross profit995,3412,171,9873,197,5365,423,076Operating expenses:Research and development1,46035,24655,220166,548Sales and marketing716,491518,5702,049,9432,341,132General and administrative806,544693,2352,864,0244,849,573Total operating expenses1,524,4951,247,0514,969,1877,357,253Operating (loss) income(529,154

)924,936(1,771,651

)(1,934,177

)Other income (expense)Interest income (expense)3473,598(3,632

)(5,062

)Gain on change in fair value of warrant derivative liability303,22215,631527,8442,685,579Other income--227,617433,958Total other income303,56919,229751,8293,114,475(Loss) income before income taxes(225,585

)944,165(1,019,822

)1,180,298Income tax (benefit) provision(2,543

)32,573(6,316

)139,862Net (loss) income(228,128

)976,738(1,026,138

)1,320,160Preferred dividends(125,498

)(14,682'/>"/>

SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... novel wearable injector slightly larger than an Oreo cookie may ... prescription drugs in the large doses required to treat a ... and genetic disorders.  An emerging biologic drugs ... to analysts.   Many of these drugs will require a new ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), ... that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... The terms of the acquisition were not disclosed. ... company providing a wide range of sleep, mobility, and respiratory ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Feb. 28, 2012 Landauer, Inc. (NYSE: LDR) ... quarterly cash dividend of $0.55 per share for the second ... 3, 2012, to shareholders of record on March 9, 2012. ... global provider of technical and analytical services to determine occupational ...
... N.C., Feb. 28, 2012  In an effort to maximize ... and biotech market research leaders must constantly evaluate the ... executives need to understand the optimal balance of external ... productivity in the quickly changing healthcare industry. ...
Cached Medicine Technology:Current Study Offers Window into Automation & Outsourcing Practices Within Top Pharmaceutical Market Research Groups 2
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... off depression among retirees, particularly among those who live ... The Journals of Gerontology, Series B: Psychological Sciences and ... Use and Depression Among Retired Older Adults in the ... that Internet use reduced the probability of a depressed ... , Late-life depression affects between 5 and 10 million ...
(Date:4/17/2014)... to find a colored ribbon representing a disease. A pink ... color ribbon does one think of with lung cancer?, Although ... suffering from the disease, black may be the only one ... lung cancer patients, primarily smokers between the ages of 51 ... stigma often felt by these patients, the emotional toll it ...
(Date:4/17/2014)... world is less than 40 years away from a ... and governments, according to a top scientist at the ... in human history, food production will be limited on ... and energy," said Dr. Fred Davies, senior science advisor ... could become as politically destabilizing by 2050 as energy ...
(Date:4/17/2014)... adrenaline after they suffer a cardiac arrest outside of ... long-term, according to new research conducted at St. Michael,s ... a cardiac arrest get adrenaline, which has been the ... Dr. Steve Lin, an emergency physician and trauma team ... treatment, long-term survival rates of patients who suffer a ...
Breaking Medicine News(10 mins):Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Food shortages could be most critical world issue by mid-century 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2
... , , , ... Association (AVMA) is unveiling a new online pre s ... the tools and resources available to journalists. , , The ... and often controversial issues in veterinary medicine as easy as possible for journalists ...
... VOORHEES, N.J., Aug. 13 The rates and severity ... by several factors, including antimicrobial use, other drug-prescribing factors, infection ... C. difficile that is more resistant to fluoroquinolones ... is crucial for healthcare professionals to be aware of these ...
... , MUMBAI, India, Aug. 13 Sun ... PHARMA, BSE: 524715) today announced that as of 11:59 p.m. ... (HSR) Act waiting period, previously granted by the U.S. Federal ... Department of Justice for the Tender Offer by Alkaloida Chemical ...
... KIBBUTZ SHAMIR, Israel, Aug. 13 Shamir Optical Industry Ltd. ... of innovative products and technology to the ophthalmic lens market, today ... 2009. , , For the quarter ended June ... million for the same period in 2008. The decrease in revenues ...
... health have found that its impact varies dramatically with age. ... bone strength in young people, it may protect against osteoporosis, ... team at the University of Edinburgh has shown that a ... by cannabis called the type 1 cannabinoid receptor (CB1) ...
... 2009: Research at the University of Liverpool has found ... dictate the physical state of superstructures. The ... distinguishable by their inability to be superimposed onto their ... just one mirror form of amino acids and DNA, ...
Cached Medicine News:Health News:AVMA Unveils Improved Online Press Room to Help Journalists 2Health News:AVMA Unveils Improved Online Press Room to Help Journalists 3Health News:Clostridium difficile Infection: Tracking a Virulent Pathogen 2Health News:Sun Pharmaceutical to File HSR Application for Taro Tender Offer 2Health News:Sun Pharmaceutical to File HSR Application for Taro Tender Offer 3Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 2Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 3Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 4Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 5Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 6Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 7Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 8Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 9Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 10Health News:Molecules wrestle for supremacy in creation of superstructures 2
Forceps, extra delicate, straight....
Jewelers Forceps, delicate, straight....
Cilia Forceps, slanted jaws, gold plated....
1 mm x 6 mm oval hole....
Medicine Products: